Thursday, February 18, 2010 7:13:19 PM
Most of the emerging countries today, where clinical research is on a growth spurt, dry ice is, all will be banned. Transportation of dry ice via air across the sea, dangerous, most pilots want to avoid all together. There is no other product on the market that I know of, that can monitor location, temperature, have a data logger with pertinent information if needed, on demand at the touch of a button, especially if the FDA notifies you, Most importantly, the sample itself, the integrity of product is key! The savings and peace of mind to the end user, priceless. One final selling point,
the benefits of switching from dry ice to our product, makes a difference on the environment.
many large corporations as well as small realize this.
Lets take the financials and last weeks 10Q. How many investors own a bio-tech company in phase one or phase two development? Their balance sheets are bloodied, but the potential of their drug is promising. CYRXD is no different. Think of CYRXD as a young Bio-Tech Company.
If what I say is so wonderful, why won't FedEx invest. The last time i checked, they were a FRT company, not a venture capitalist company. If the products so great ,why can't we sign customers.
Two-fold, one, no money to expand, and secondly, a customer starting full scale with CYRXD currently, a dangerous proposal at best, because of balance sheet risk.
That leads us to now, the present, how do we satisfy the customers? How do we expand and grow the company? we need money. Until that money is secured, you're suspended.
Now this is where a gent like Tiger comes in. He understands this game probably better than most of us. His past experiences are a valuable tool to this board. This is something I don't understand and have always been the first to admit. But if my Buddy Tiger wants to debate me about the capital that is needed to ramp up, he lose every time.
I will say this in closing, there are many ways to skin a cat, and when the time is right,
this company will be a nice little growth story.
I extended the personal e-mail address, if anyone wants to use it while we wait for CYRXD to resolve their capital issues. once resolved, this company will do just fine.
Again all the best to everyone, and good luck!
CP
Recent CYRX News
- Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus • PR Newswire (US) • 10/07/2024 12:30:00 PM
- SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices • PR Newswire (US) • 09/25/2024 12:30:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/03/2024 08:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 11:11:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:28:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 06:55:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 12:00:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 09:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:34:57 PM
- Cryoport Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/06/2024 08:15:00 PM
- Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes • PR Newswire (US) • 08/06/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/02/2024 08:22:37 PM
- Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024 • PR Newswire (US) • 07/23/2024 12:30:00 PM
- Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies • PR Newswire (US) • 06/20/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/14/2024 08:31:02 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2024 08:45:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 09:10:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:03:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:01:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 11:28:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:53:55 PM
- Cryoport Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/07/2024 08:08:00 PM
- Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024 • PR Newswire (US) • 04/30/2024 12:30:00 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM